Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT05900570

Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure

Led by Corewell Health East · Updated on 2025-12-11

20

Participants Needed

1

Research Sites

148 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this early feasibility prospective study is to gain initial understanding of the effect of acute peri-urethral neurostimulation on the perineal nerves on intra-urethral pressure.

CONDITIONS

Official Title

Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 18 years old or older
  • Able to understand the study procedures and give informed consent
  • Willing and able to undergo the study procedure
  • Diagnosed with stress urinary incontinence or stress predominant mixed incontinence for at least 6 months
  • Provided permission to use and disclose information for research purposes
Not Eligible

You will not qualify if you...

  • Predominant urge incontinence reported by patient or medical record
  • Active uncontrolled bladder instability as decided by the investigator
  • Regular or intermittent use of a urethral catheter
  • Active bladder cancer or current treatment for bladder cancer
  • Previous radiation treatment in the pelvic floor area
  • History or symptoms of severe cystocele, enterocele, or rectocele (grade 3 or 4)
  • Current infection such as urethritis, cystitis, or vaginitis
  • Active genital herpes
  • Unevaluated blood in urine
  • Use of pharmacological treatment for stress urinary incontinence within 4 weeks prior to screening
  • Severe or uncontrolled diabetes (hemoglobin A1c of 10% or higher)
  • History of drug or alcohol abuse, mental dysfunction, or other factors limiting cooperation
  • Positive pregnancy test during screening or currently breastfeeding
  • Pregnant or given birth within the last 12 months
  • Implanted active neurostimulators, pacemakers, or defibrillators that cannot be turned off for the procedure
  • Known neurological disorders
  • Severe coagulation disorders
  • Medically unstable or unsafe for urodynamic testing
  • Presence of an artificial urinary sphincter
  • Any medical condition or uncontrolled chronic disease that affects ability to comply or safety as determined by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Corewell Health William Beaumont University Hospital

Royal Oak, Michigan, United States, 48073

Actively Recruiting

Loading map...

Research Team

J

Jennifer Giordano, BSN

CONTACT

A

Amanda Schonhoff, BSN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here